T1 signal intensity ratio of the pancreas as an imaging biomarker for the staging of chronic pancreatitis
Authors:
Temel Tirkes, Anil K. Dasyam, Zarine K. Shah, Evan L. Fogel, Santhi Swaroop Vege, Liang Li, Shuang Li, Stephanie T. Chang, Carlos A. Farinas, Joseph R. Grajo, Kareem Mawad, Naoki Takahashi, Sudhakar K. Venkatesh, Ashley Wachsman, William E. Fisher, Christopher E. Forsmark, Phil A. Hart, Stephen J. Pandol, Walter G. Park, Stephen K. Van Den Eeden, Yunlong Yang, Mark Topazian, Dana K. Andersen, Jose Serrano, Darwin L. Conwell, Dhiraj Yadav, The Consortium for the Study of Chronic Pancreatitis, Diabetes, Pancreatic Cancer (CPDPC)
Our purpose was to validate the T1 SIR (T1 score) as an imaging biomarker for the staging of CP in a large, multi-institutional, prospective study.
Methods
The prospective study population included 820 participants enrolled in the PROCEED study from nine clinical centers between June 2017 and December 2021. A radiologist at each institution used a standardized method to measure the T1 signal intensity of the pancreas and the reference organs (spleen, paraspinal muscle, liver), which was used to derive respective T1 scores. Participants were stratified according to the seven mechanistic stages of chronic pancreatitis (MSCP 0–6) based on their clinical history, MRCP, and CT findings.
Results
The mean pancreas-to-spleen T1 score was 1.30 in participants with chronic abdominal pain, 1.22 in those with acute or recurrent acute pancreatitis, and 1.03 in definite CP. After adjusting for covariates, we observed a linear, progressive decline in the pancreas-to-spleen T1 score with increasing MSCP from 0 to 6. The mean pancreas-to-spleen T1 scores were 1.34 (MSCP 0), 1.27 (MSCP 1), 1.21 (MSCP 2), 1.16 (MSCP 3), 1.18 (MSCP 4), 1.12 (MSCP 5), and 1.05 (MSCP 6) (p < 0.0001). The pancreas-to-liver and pancreas-to-muscle T1 scores showed less linear trends and wider confidence intervals.
Conclusion
The T1 score calculated by SIR of the pancreas-to-spleen shows a negative linear correlation with the progression of chronic pancreatitis. It holds promise as a practical imaging biomarker in evaluating disease severity in clinical research and practice.
T1 signal intensity ratio of the pancreas as an imaging biomarker for the staging of chronic pancreatitis
Authors
Temel Tirkes Anil K. Dasyam Zarine K. Shah Evan L. Fogel Santhi Swaroop Vege Liang Li Shuang Li Stephanie T. Chang Carlos A. Farinas Joseph R. Grajo Kareem Mawad Naoki Takahashi Sudhakar K. Venkatesh Ashley Wachsman William E. Fisher Christopher E. Forsmark Phil A. Hart Stephen J. Pandol Walter G. Park Stephen K. Van Den Eeden Yunlong Yang Mark Topazian Dana K. Andersen Jose Serrano Darwin L. Conwell Dhiraj Yadav The Consortium for the Study of Chronic Pancreatitis, Diabetes, Pancreatic Cancer (CPDPC)
WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.